PETMED EXPRESS INC
Price data unavailable
Track PETS in your trading journalAbout PETMED EXPRESS INC
PETMED EXPRESS INC (PETS) is a publicly listed company on US equity markets.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.
The company reports trailing twelve-month revenue of $74.29M and net loss of $10.55M.
Key metrics include a return on equity of -32.2%, a debt-to-equity ratio of 1.68.
Use FINOTAUR to track PETS's price action, review fundamentals, and stay current with company news — all in one research dashboard.
Fundamentals
| Revenue (TTM) | $74.29M |
| Net Income (TTM) | $-10.55M |
| EPS (TTM) | — |
| P/E Ratio | — |
| Return on Equity | -32.21% |
| Debt-to-Equity | 1.68 |
| Dividend per Share | — |
Recent News
- Benzinga·Dec 17
Cardone Ventures Offers Full Buyout Of PetMed Express, Stock Soars
- GlobeNewswire Inc.·Dec 10
PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets and the People Who Love Them
- GlobeNewswire Inc.·Nov 1
PETMED EXPRESS INVESTIGATION: Bragar Eagel & Squire, P.C. Reminds PetMed Express Investors of the Ongoing Investigation on Behalf of Stockholders
Want real-time analysis on PETS?
Track it free in your trading journal. Log trades, tag setups, and review your edge.